Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...

Rates of severe infection after transrectal ultrasound-guided (TRUS) prostate biopsy that require hospitalization are on the rise, a population-based Swedish study shows. "Over 100,000 biopsies are ...

Misdiagnoses in prostate biopsy patients lead to $880M in healthcare costs On average, roughly one in every 200 patients undergoing a prostate biopsy are misdiagnosed due to their biopsy specimens ...

Combining MRI-guided biopsy of the prostate with conventional ultrasound-guided 12-core prostate biopsy was superior to either technique alone at ruling out more aggressive cancers, and beat ...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...

It's common for healthcare professionals to order biopsies for patients whom they suspect may have prostate cancer. A biopsy ...

Research into magnetic resonance imaging (MRI) for prostate cancer screening and diagnosis has been ongoing for more than a decade. Initially, MRI was thought to be important for achieving two goals.

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and performing only targeted biopsy of MRI-positive lesions, eliminated more than half ...